Cancer Stories
Didn't see your exact story?
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
Cancer Stories
Search by cancer type, stage, biomarker or treatment to find people who've been exactly where you are.
Discuss
PatientSavvy: Join us
A 72-year-old woman was diagnosed with Stage III gastric adenocarcinoma involving the antrum. She underwent partial gastrectomy with extensive lymph-node dissection. Pathology showed a poorly differentiated mixed-type adenocarcinoma with signet-ring cells and linitis plastica features involving the antrum and pylorus. Adjuvant capecitabine plus oxaliplatin was started after surgery, but she could not tolerate the treatment and it was discontinued. Ten months after surgery, CT showed a destructive bone lesion in the upper thoracic spine and enlarged left inguinal lymph nodes, indicating distant recurrence. Palliative radiation to the bone lesion provided substantial pain relief.
Over the following months, swelling developed in one leg and then both legs, progressing to severe lymphedema. She was hospitalized with extensive skin infiltration involving the lower limbs and extending toward the abdomen and upper-limb roots. A skin biopsy showed signet-ring carcinoma cells filling lymphatic vessels in the skin and subcutaneous tissue, confirming carcinomatous lymphangitis from the gastric cancer.
Palliative chemotherapy was started, but the metastatic disease continued to worsen. She developed respiratory failure and died. Because the cancer had spread to bone, distant lymph nodes and skin, her latest and highest documented stage is Stage IV.
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer